Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Non-Standardized Pollen Allergenic Extract [EPC]
Holcus Lanatus Pollen is a non-standardized allergenic extract used in the diagnosis and treatment of grass-pollen-induced allergic rhinitis and asthma. It belongs to the class of allergenic extracts used for immunotherapy to induce immunological tolerance.
Name
Holcus Lanatus Pollen
Raw Name
HOLCUS LANATUS POLLEN
Category
Non-Standardized Pollen Allergenic Extract [EPC]
Drug Count
5
Variant Count
5
Last Verified
February 17, 2026
About Holcus Lanatus Pollen
Holcus Lanatus Pollen is a non-standardized allergenic extract used in the diagnosis and treatment of grass-pollen-induced allergic rhinitis and asthma. It belongs to the class of allergenic extracts used for immunotherapy to induce immunological tolerance.
Detailed information about Holcus Lanatus Pollen
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Holcus Lanatus Pollen.
Holcus Lanatus Pollen, commonly known as Velvet Grass or Yorkshire Fog pollen, is a biological substance utilized in the field of clinical allergy and immunology. It belongs to the pharmacological class known as Non-Standardized Pollen Allergenic Extracts [EPC]. These extracts are prepared from the pollen of the Holcus lanatus plant, a perennial grass species widely distributed in temperate regions. According to the FDA’s Center for Biologics Evaluation and Research (CBER), these extracts are indicated for use in both diagnostic testing (via skin prick or intradermal methods) and therapeutic applications, specifically Allergen Immunotherapy (AIT), often referred to as 'allergy shots.'
As a member of the Poaceae family, Holcus lanatus contains several potent allergens, most notably Hol l 1 and Hol l 5, which are proteins that trigger IgE-mediated allergic responses in sensitized individuals. When a patient is diagnosed with a specific grass pollen allergy through clinical history and positive skin tests, a healthcare provider may prescribe Holcus Lanatus Pollen extract to help desensitize the immune system. The goal of this treatment is to reduce the severity of symptoms associated with allergic rhinitis (hay fever), allergic conjunctivitis, and allergic asthma. The FDA has historically licensed these extracts under the Public Health Service Act, though many remain 'non-standardized,' meaning their potency is not measured in Bioequivalent Allergy Units (BAU) but rather by weight/volume (w/v) or Protein Nitrogen Units (PNU).
Holcus Lanatus Pollen extract works through a complex immunological process known as desensitization or allergen immunotherapy. At the molecular level, the administration of gradually increasing doses of the pollen extract alters the way the immune system perceives and reacts to the allergen. In an allergic individual, exposure to Holcus lanatus pollen normally triggers a Type I hypersensitivity reaction, where allergen-specific Immunoglobulin E (IgE) antibodies bind to mast cells and basophils, leading to the release of histamine, leukotrienes, and other inflammatory mediators.
When a healthcare provider administers Holcus Lanatus Pollen extract via subcutaneous injection (SCIT), it initiates a shift in the immune profile. Research published in the Journal of Allergy and Clinical Immunology suggests that successful immunotherapy involves the induction of regulatory T cells (Tregs), which produce anti-inflammatory cytokines like Interleukin-10 (IL-10) and Transforming Growth Factor-beta (TGF-β). These cytokines suppress the allergic Th2 response and promote the production of 'blocking antibodies,' specifically Immunoglobulin G4 (IgG4). These IgG4 antibodies compete with IgE for allergen binding sites, effectively preventing the allergic cascade before it begins. Over months and years, this treatment leads to long-term immunological tolerance, even after the therapy is discontinued.
Traditional pharmacokinetic studies (Absorption, Distribution, Metabolism, and Elimination) are difficult to apply to allergenic extracts like Holcus Lanatus Pollen because they are complex mixtures of proteins rather than single chemical entities. However, the following principles apply to their biological processing:
Holcus Lanatus Pollen is primarily used for two clinical purposes:
Holcus Lanatus Pollen extract is typically available in the following forms:
> Important: Only your healthcare provider can determine if Holcus Lanatus Pollen is right for your specific condition. The selection of the extract and the concentration used must be tailored to your individual sensitivity levels.
The dosage for Holcus Lanatus Pollen immunotherapy is highly individualized and follows a two-phase approach: the Build-up Phase and the Maintenance Phase. There is no 'standard' dose for all patients, as the concentration must be adjusted based on the patient's sensitivity.
During this phase, the healthcare provider begins with a very low dose of a highly diluted extract (e.g., 1:100,000 w/v). Injections are typically given 1 to 3 times per week. The dose is gradually increased with each injection until the target 'maintenance dose' is reached. This phase usually lasts 3 to 6 months.
Once the maintenance dose is achieved, the frequency of injections is reduced. Patients typically receive the same dose once every 2 to 4 weeks. This phase is generally continued for 3 to 5 years to ensure long-lasting immunity. The maintenance dose is often the highest concentration that the patient can tolerate without significant local or systemic side effects, frequently ranging from 0.5 mL of a 1:100 or 1:10 w/v solution.
Holcus Lanatus Pollen extracts are generally approved for use in children, provided the child is old enough to cooperate with the injection procedure and communicate symptoms of a systemic reaction.
No specific dosage adjustments are required for patients with renal impairment, as the proteins are not cleared by the kidneys in a manner that would lead to toxicity.
No dosage adjustments are necessary for hepatic impairment. The metabolism of allergenic proteins is independent of the cytochrome P450 system.
Caution is advised in elderly patients, particularly those with underlying cardiovascular disease. The risk-benefit ratio must be carefully weighed, as the elderly may be less able to tolerate the physiological stress of a systemic reaction or the administration of epinephrine.
Holcus Lanatus Pollen extract must ONLY be administered by a healthcare professional in a clinical setting equipped to treat anaphylaxis.
Consistency is critical in immunotherapy. If a dose is missed, the next dose may need to be reduced to prevent a reaction, especially during the build-up phase.
An overdose of Holcus Lanatus Pollen extract occurs if a patient receives a dose higher than their current tolerance level. This can lead to severe local reactions or systemic anaphylaxis.
> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose or skip appointments without medical guidance.
Most patients undergoing immunotherapy with Holcus Lanatus Pollen will experience some form of local reaction. These are generally considered a normal part of the body's response to the extract.
These reactions are more significant and may require a modification of the dosing schedule.
> Warning: Stop taking Holcus Lanatus Pollen immunotherapy and call your doctor immediately or seek emergency services if you experience any of the following symptoms of anaphylaxis.
Holcus Lanatus Pollen immunotherapy is generally considered safe for long-term use (3-5 years). There is no evidence that it causes autoimmune diseases or chronic organ damage. The primary 'long-term' effect is the desired one: a significant reduction in allergy symptoms and a decreased risk of developing new sensitizations or progressing from allergic rhinitis to asthma.
Allergenic extracts, including Holcus Lanatus Pollen, carry an FDA-mandated Black Box Warning regarding the risk of severe systemic reactions.
Report any unusual symptoms to your healthcare provider, even if they seem minor at the time.
Holcus Lanatus Pollen extract is a potent biological product that must be handled with extreme care. It is not a medication you take at home; it is a clinical procedure. Patients must be in stable health on the day of their injection. If you are feeling ill, have a fever, or are experiencing an asthma flare-up, you must notify your doctor, as your injection will likely be postponed.
No FDA black box warnings for Holcus Lanatus Pollen? No, that is incorrect. Holcus Lanatus Pollen extracts do carry a Black Box Warning. The warning emphasizes that these extracts can cause severe systemic reactions, including fatal anaphylaxis. It states that the extract should only be administered in a setting where emergency resuscitative equipment and trained personnel are immediately available. Furthermore, it warns that patients with severe or unstable asthma, or those taking certain medications like beta-blockers, are at increased risk.
There are no standard laboratory tests (like blood counts) required for Holcus Lanatus Pollen therapy. Instead, monitoring is clinical:
Most patients can drive and operate machinery after their 30-minute observation period. However, if you feel dizzy, fatigued, or 'off' after your injection, you should avoid these activities until you feel fully recovered. If a systemic reaction occurs and epinephrine is administered, you should not drive.
There is no direct chemical interaction between alcohol and Holcus Lanatus Pollen extract. However, alcohol can cause vasodilation (widening of blood vessels), which may theoretically increase the speed of allergen absorption or worsen the severity of an allergic reaction. It is generally recommended to avoid heavy alcohol consumption on the day of your injection.
Immunotherapy can be stopped at any time without 'withdrawal' symptoms. However, if stopped prematurely (before 3 years), the allergic symptoms are likely to return. If you wish to discontinue treatment, discuss a plan with your allergist to ensure your symptoms are managed through other means.
> Important: Discuss all your medical conditions with your healthcare provider before starting Holcus Lanatus Pollen.
While there are few absolute 'drug-drug' contraindications, certain combinations significantly increase the danger of the procedure:
There are no known specific food interactions with Holcus Lanatus Pollen. However, patients with 'Oral Allergy Syndrome' (Pollen-Food Allergy Syndrome) may find that their sensitivity to certain raw fruits or vegetables (which share cross-reactive proteins with grasses) changes during the course of immunotherapy.
There is limited data on herbal interactions. However, any supplement that affects the immune system (such as Echinacea or high-dose Astragalus) should be discussed with your allergist, as they could theoretically interfere with the desensitization process.
Holcus Lanatus Pollen extract will affect the results of:
For each major interaction, the management strategy is usually avoidance or extreme caution. For example, if a patient requires a beta-blocker, the allergist may consult with a cardiologist to switch to an alternative class of medication before starting immunotherapy.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking.
Holcus Lanatus Pollen extract must NEVER be used in the following circumstances:
These conditions require a careful risk-benefit analysis by the healthcare provider:
Patients allergic to Holcus Lanatus Pollen are almost always cross-sensitive to other grasses in the Poaceae family, such as Timothy Grass (Phleum pratense), Orchard Grass (Dactylis glomerata), and Kentucky Bluegrass (Poa pratensis). This is due to the high degree of structural similarity between grass pollen proteins. If you have had a severe reaction to one grass extract, you are at high risk for a reaction to Holcus Lanatus Pollen.
> Important: Your healthcare provider will evaluate your complete medical history before prescribing Holcus Lanatus Pollen.
Pregnancy Category: C (According to older FDA standards still applied to many extracts).
Holcus Lanatus Pollen extracts are not known to pass into breast milk in any significant way. The proteins are digested in the mother's body. Breastfeeding is generally considered safe for women receiving immunotherapy. There is no evidence of harm to the nursing infant.
Immunotherapy is highly effective in children and may prevent the 'allergic march' (the progression from hay fever to asthma).
In patients over 65, the decision to use Holcus Lanatus Pollen must be individualized.
There are no specific guidelines for renal impairment. Because the allergens are proteins that are degraded locally and systemically by proteases, renal function does not typically impact the safety or efficacy of the treatment.
No adjustments are needed for patients with liver disease. The liver does not play a primary role in the clearance of these allergenic proteins.
> Important: Special populations require individualized medical assessment to ensure the benefits of immunotherapy outweigh the potential risks.
Holcus Lanatus Pollen extract functions by inducing 'immunological desensitization.' The primary molecular mechanism involves the modulation of the T-cell response. In an allergic state, the body favors a Th2 (T-helper type 2) response, which produces cytokines like IL-4 and IL-5, promoting IgE production.
Immunotherapy induces a shift toward a Th1 response and, more importantly, stimulates the production of CD4+ CD25+ regulatory T cells (Tregs). These Tregs secrete Interleukin-10 (IL-10), which has several effects:
| Parameter | Value |
|---|---|
| Bioavailability | N/A (Subcutaneous administration) |
| Protein Binding | N/A (Proteins are processed by APCs) |
| Half-life | Varies (Proteins degraded within hours to days) |
| Tmax | 1-2 hours (Peak systemic absorption of allergens) |
| Metabolism | Proteolytic degradation by cellular enzymes |
| Excretion | Minimal renal/fecal excretion of intact proteins |
Holcus Lanatus Pollen is classified as an Allergenic Extract. It is further categorized as a Non-Standardized Extract, distinguished from 'Standardized' extracts (like Timothy Grass) which have federally mandated potency requirements. It is part of the broader category of Biologicals used in immunotherapy.
Common questions about Holcus Lanatus Pollen
Holcus Lanatus Pollen extract is primarily used for the diagnosis and treatment of allergies to Velvet Grass (also known as Yorkshire Fog). In a diagnostic setting, it is used in skin prick tests to identify if a patient has an IgE-mediated sensitivity to this specific grass. Therapeutically, it is used in allergen immunotherapy, commonly known as allergy shots, to desensitize the immune system over time. This treatment is indicated for patients with allergic rhinitis, conjunctivitis, or asthma that is triggered by grass pollen. The goal is to reduce the severity of symptoms and the need for daily allergy medications.
The most common side effects are local reactions at the site of the subcutaneous injection, which occur in the majority of patients. These typically include redness, swelling, itching, and a firm wheal that may feel like a large insect bite. These reactions usually appear within minutes and can last for 24 to 48 hours. Some patients may also experience mild systemic symptoms like sneezing, nasal congestion, or a slight feeling of fatigue following the injection. While these are common and usually manageable, any reaction that is large or spreads beyond the injection site should be reported to your doctor.
There is no direct chemical interaction between alcohol and the proteins in Holcus Lanatus Pollen extract. However, healthcare providers generally advise caution regarding alcohol consumption on the day of an allergy injection. Alcohol can cause blood vessels to dilate, which might theoretically increase the speed at which the allergen is absorbed into the bloodstream, potentially increasing the risk of a systemic reaction. Additionally, alcohol can impair your ability to recognize early symptoms of anaphylaxis. It is best to discuss your alcohol consumption habits with your allergist before starting treatment.
Holcus Lanatus Pollen is generally not started during pregnancy because of the risk of a severe allergic reaction (anaphylaxis), which could be life-threatening for both the mother and the fetus. However, if a woman is already on a stable maintenance dose of immunotherapy and becomes pregnant, most allergists agree that it is safe to continue the treatment at that same dose. The treatment does not cause birth defects, but the risk lies in the potential for a reaction to the injection itself. Always inform your healthcare provider immediately if you become pregnant while receiving allergy shots so they can adjust your treatment plan accordingly.
Immunotherapy is a long-term treatment and does not provide immediate relief like an antihistamine or a nasal spray. Most patients begin to notice a decrease in their allergy symptoms during the first grass pollen season after they have reached their maintenance dose, which usually takes 3 to 6 months of weekly injections. Significant and lasting improvement typically requires at least one full year of treatment. For the most durable results and long-term protection even after stopping the shots, a full course of 3 to 5 years is generally recommended by clinical guidelines.
Yes, you can stop taking Holcus Lanatus Pollen injections suddenly without experiencing any physical withdrawal symptoms, as it is not an addictive substance. However, stopping the treatment before the recommended 3-to-5-year mark significantly increases the likelihood that your allergy symptoms will return. If you stop during the build-up phase, you will likely see no long-term benefit at all. If you are considering stopping your allergy shots due to side effects, cost, or scheduling issues, you should first discuss your concerns with your allergist to see if the protocol can be adjusted.
If you miss a dose of Holcus Lanatus Pollen, you should contact your allergist's office as soon as possible to reschedule. Do not simply wait until your next scheduled appointment without calling. Because immunotherapy relies on building and maintaining tolerance, missing a dose may mean that your next dose needs to be reduced to ensure safety. If too much time passes between injections (usually more than 4 weeks), your doctor may need to 'roll back' your dose to a lower concentration and restart the build-up process to avoid a systemic reaction.
There is no scientific evidence or clinical data to suggest that Holcus Lanatus Pollen allergenic extracts cause weight gain. The extract consists of proteins and small amounts of preservatives that do not affect the body's metabolism, appetite, or fat storage. If you experience weight changes while undergoing immunotherapy, they are likely due to other factors such as lifestyle changes, other medications (like oral steroids sometimes used for asthma), or unrelated medical conditions. You should discuss any unexpected weight changes with your primary care physician.
Holcus Lanatus Pollen can be taken alongside most common medications, but there are critical exceptions. You must inform your doctor if you are taking beta-blockers (often used for heart disease or migraines), as they can make an allergic reaction much more dangerous and difficult to treat. ACE inhibitors and MAOIs also require careful consideration. Most standard allergy medications like antihistamines, leukotriene modifiers, and nasal steroids are actually encouraged during the build-up phase to help manage symptoms, though they should be used consistently so they don't mask the early signs of an injection reaction.
The concept of 'generic' drugs does not apply to allergenic extracts in the same way it does to chemical tablets. Holcus Lanatus Pollen is a biological product, and various manufacturers produce their own versions of the extract. While these extracts may be used interchangeably by an allergist, they are not considered 'generic' versions of one another. Each manufacturer's extract may have slight variations in protein concentration and potency. Therefore, once you begin treatment with a specific brand or vial, your doctor will usually try to keep you on that same manufacturer's product or carefully adjust the dose if switching.